{"id":55801,"date":"2023-04-13T18:04:14","date_gmt":"2023-04-13T16:04:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/"},"modified":"2023-04-13T18:04:14","modified_gmt":"2023-04-13T16:04:14","slug":"verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/","title":{"rendered":"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead"},"content":{"rendered":"
\n

\nMerger meets growing demand by combining strengths and accelerating investment in people, technology, and service to lead the industry forward<\/i><\/p>\n

<\/a><\/p>\n

WASHINGTON–(BUSINESS WIRE)–Verisma<\/a>, a trusted disclosure management partner servicing diverse healthcare environments with their most complicated release challenges, and ScanSTAT<\/a>, Release of Information (ROI) experts specializing in physician groups, ambulatory services, health systems and hospitals with expanded health information management (HIM) solutions, announced a merger of the two companies, creating a new market leader in Release of Information. Coming together under the Verisma brand, the combined company provides faster turnaround times through automation, expanded services to manage compliance requirements, and advanced tools to improve patient experience.<\/p>\n

\n\u201cThe technology and service experts coming together is a response to a very real demand we see from HIM departments,\u201d said Verisma CEO Marty McKenna. \u201cIncreasingly, scale and sophistication are essential to ensure we evolve with the market and create more efficient ways to protect our clients and their patients. ScanSTAT has veteran experience, white glove service, and expanded HIM services that naturally complement our broader technology and service capabilities. Together, we now deliver a comprehensive market-leading ROI solution \u2013 a sophisticated, reliable, and efficient platform that can be customized to the unique needs of different types of providers.\u201d<\/p>\n

\nWith combined strengths and resources, Verisma and ScanSTAT can scale investments in people, technology, and services that will lead the HIM industry forward.<\/p>\n

\n\u201cOur companies share the view that sophisticated ROI is no longer optional,\u201d said ScanSTAT CEO, Matt Rohs, who will take on the role of Chief of Staff in the combined company and join the Verisma Board of Directors. \u201cVerisma and ScanSTAT uniting is a natural move for both of us as providers seek experts to help simplify the complicated world of ROI.\u201d<\/p>\n

\nNewSpring Healthcare<\/a>, NewSpring\u2019s<\/a> dedicated healthcare strategy and an existing investor in Verisma, provided funding to facilitate the transaction.<\/p>\n

\n\u201cThroughout our partnership with Verisma, the company has grown into a market leader in disclosure management and exceeded our high expectations for the business,\u201d said Matt Plevelich, Principal at NewSpring Healthcare. \u201cVerisma still has significant runway for further growth and we are thrilled to provide funding for this merger that will help the company continue to expand and improve the overall experience for healthcare providers and third-party requestors.\u201d<\/p>\n

\nGuggenheim Securities, LLC acted as exclusive financial advisor to ScanSTAT on this transaction.<\/p>\n

\nAbout Verisma<\/b><\/p>\n

\nWith Verisma\u00ae services and technology, health information managers elevate their organization\u2019s method of securely disclosing confidential information to patients, attorneys, and other third parties. Built on the principles of truth and accuracy, Verisma is a trusted partner in complying with changing regulations while reducing errors, turnaround time, and cost. Verisma HITRUST\u00ae certified technology integrates with existing EHRs and portals for advanced automation and transparency uniquely designed for release of information (ROI), self-serve request tracking, and audits. Flexible service models including full-service, technology-only, or a hybrid seamlessly blend Verisma\u2019s end-to-end solution with the needs of existing staff. Our partnership is truly a promise to put patient protection first. Learn more about our disclosure management system at verisma.com<\/a>.<\/p>\n

\nAbout <\/b>ScanSTAT<\/b><\/p>\n

\nScanSTAT always strives to stay ahead of the curve. Our combination of technology, expertise, HIPAA-compliant processes, and ability to deliver a suite of high-quality health information management services sets ScanSTAT apart from the industry. Our highly trained health information management experts help you increase efficiency and remain compliant with HIPAA regulations. ScanSTAT is a proud partner to some of the industry\u2019s best electronic health record (EHR) systems. Learn more at scanstat.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nDelinda Tinkey
\n
Verisma
\n
866.390.7404
\n
dtinkey@verisma.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Merger meets growing demand by combining strengths and accelerating investment in people, technology, and service to lead the industry forward WASHINGTON–(BUSINESS WIRE)–Verisma, a trusted disclosure management partner servicing diverse healthcare environments with their most complicated release challenges, and ScanSTAT, Release of Information (ROI) experts specializing in physician groups, ambulatory services, health systems and hospitals with … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55801","6":"format-standard","7":"category-industry"},"yoast_head":"\nVerisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Merger meets growing demand by combining strengths and accelerating investment in people, technology, and service to lead the industry forward WASHINGTON–(BUSINESS WIRE)–Verisma, a trusted disclosure management partner servicing diverse healthcare environments with their most complicated release challenges, and ScanSTAT, Release of Information (ROI) experts specializing in physician groups, ambulatory services, health systems and hospitals with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-13T16:04:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230413005503\/en\/1760252\/21\/Verisma_Logo_Horz_RGB_600.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead\",\"datePublished\":\"2023-04-13T16:04:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/\"},\"wordCount\":611,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005503\\\/en\\\/1760252\\\/21\\\/Verisma_Logo_Horz_RGB_600.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/\",\"name\":\"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005503\\\/en\\\/1760252\\\/21\\\/Verisma_Logo_Horz_RGB_600.jpg\",\"datePublished\":\"2023-04-13T16:04:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005503\\\/en\\\/1760252\\\/21\\\/Verisma_Logo_Horz_RGB_600.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005503\\\/en\\\/1760252\\\/21\\\/Verisma_Logo_Horz_RGB_600.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/","og_locale":"en_US","og_type":"article","og_title":"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead - Pharma Trend","og_description":"Merger meets growing demand by combining strengths and accelerating investment in people, technology, and service to lead the industry forward WASHINGTON–(BUSINESS WIRE)–Verisma, a trusted disclosure management partner servicing diverse healthcare environments with their most complicated release challenges, and ScanSTAT, Release of Information (ROI) experts specializing in physician groups, ambulatory services, health systems and hospitals with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-13T16:04:14+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230413005503\/en\/1760252\/21\/Verisma_Logo_Horz_RGB_600.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead","datePublished":"2023-04-13T16:04:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/"},"wordCount":611,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005503\/en\/1760252\/21\/Verisma_Logo_Horz_RGB_600.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/","url":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/","name":"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005503\/en\/1760252\/21\/Verisma_Logo_Horz_RGB_600.jpg","datePublished":"2023-04-13T16:04:14+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230413005503\/en\/1760252\/21\/Verisma_Logo_Horz_RGB_600.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230413005503\/en\/1760252\/21\/Verisma_Logo_Horz_RGB_600.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/verisma-and-scanstat-announce-merger-providing-the-strength-and-know-how-that-him-departments-need-for-the-path-ahead\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Verisma and ScanSTAT Announce Merger, Providing the Strength and Know-How that HIM Departments Need for the Path Ahead"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55801"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55801\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}